ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1509 National Cancer Institute Html en Ovarian Low Malignant Potential Tumors Treatment (PDQ®)–Health Professional Version Expert-reviewed information summary about the treatment of ovarian low-malignant potential tumors.
actuarial survival rate0.630338
significantly higher incidence0.497662
survival rates0.647886
excellent survival rates0.613575
ovarian cystic neoplasms0.524669
large series0.505974
advanced-stage tumors0.534809
survival rate0.991192
serous tumors0.508069
aggressive cytoreductive surgery0.508958
intraperitoneal disease0.508061
gross residual tumor0.624183
DNA ploidy0.473971
presumed localized tumors0.627355
primary serous tumor0.543013
patients0.874529
gross residual disease.0.554008
small bowel obstruction0.517717
20-year survival rates0.623524
total abdominal hysterectomy0.500134
malignant potential tumors0.654434
epithelial ovarian cancers0.560469
positive lymph nodes0.513754
secondary cytoreductive procedure0.496028
malignant invasive carcinomas0.598953
Oncology Group study0.492475
borderline ovarian tumors0.602765
early-stage disease0.53696
borderline tumors0.543947
7-year survival rate0.610698
aneuploid tumors0.485651
low malignant potential0.549837
gross residual disease0.749508
tumor recurrence0.473805
so-called invasive implants0.548607
low malignant potential.0.544407
invasive tumors0.531513
negative lymph nodes0.509204
radiation therapy alters0.492888
borderline tumor0.475678
d’Obstetrique Annual Report0.515222
tumor reductive surgery0.541448
aneuploid invasive implants0.511492
invasive implants0.72297
life table analysis0.517429
tumors0.678345
completely resected tumor0.568634
residual tumor0.843362
large prospective study.0.509685
CLICK HERE
1526 National Cancer Institute Html en Nasopharyngeal Cancer Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of nasopharyngeal cancer.
clinical trial0.341084
treatment0.278725
clinical trial search0.201632
cancer clinical trials0.224875
lymph nodes0.503913
radiation therapy0.653094
National Cancer Institute0.229813
cancer0.952582
nasopharyngeal cancer0.779979
clinical trials0.675026
affected lymph nodes0.35443
CLICK HERE
1575 National Cancer Institute Html en Primary CNS Lymphoma Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of primary CNS lymphoma.
treatment0.59441
malignant tumor cells0.410902
cancer treatment0.387562
magnetic resonance imaging0.302981
AIDS-Related Lymphoma Treatment0.38242
cancer cells0.552497
diagnose primary CNS0.376869
cancer spreads0.314799
body0.390696
chemotherapy0.325347
Cancer Information Service0.293659
PDQ cancer information0.395799
treatment clinical trials0.330856
National Cancer Institute0.418327
clinical trials0.79992
spinal cord0.477649
normal cells0.306785
CNS lymphoma spreads0.36676
cancer information summary0.355271
high-dose chemotherapy0.312805
clinical trial0.527292
lymph vessels0.292112
new treatment0.386702
stem cell transplant0.3294
detailed pictures0.29332
patients0.363752
external radiation therapy0.330212
blood0.30715
nuclear magnetic resonance0.30502
bone marrow0.337702
PDQ summary0.321843
brain radiation therapy0.396953
treatment clinical trial0.299448
lymphoma cells0.314276
NCI PDQ cancer0.30844
tests0.319628
primary intraocular lymphoma0.315344
cancer clinical trials0.309551
metastatic CNS lymphoma0.367075
radiation therapy0.605061
treatment options0.328184
Treatment Editorial Board0.31416
primary cns0.98741
cancer0.865897
standard treatment0.301659
positron emission tomography0.306717
CLICK HERE
1757 National Cancer Institute Html en Biological Therapies for Cancer A fact sheet that provides an overview of how the immune system functions and describes the actions of biological therapies.
red blood cells0.577776
cancer vaccines0.49997
certain cells0.540439
human cells0.554952
healthy cells0.559468
immune responses0.496164
dendritic cells0.583067
white blood cells0.751432
activated T cells0.553284
Targeted Cancer Therapies0.4932
clinical trials0.665835
anticancer immune response0.557063
reproductive cells0.533783
cancer treatment vaccines0.521084
stem cells0.582774
biological therapies0.676853
biological therapy0.585141
gene therapy0.624656
cancer cell surface0.49085
metastatic breast cancer0.502756
blood-forming stem cells0.552734
dead cells0.564287
oncolytic viruses0.562901
oncolytic virus therapy0.524139
breast cancer cells0.605883
abnormal cells0.587571
non-Hodgkin lymphoma cells0.585453
receptor-modified T cells0.533588
Severe allergic reaction0.495224
cancer cells0.939837
killer T cells0.545739
tumour cells0.53329
immune response0.649552
antibody-producing cells0.554007
blood stem cells0.57668
tumor cells0.642236
normal cells0.598729
identical daughter cells0.56732
immune cells0.615338
bladder cancer cells0.599791
laboratory-grown T cells0.538366
natural killer cells0.629042
cells0.962945
cancer clinical trials0.496931
cytotoxic t cells0.651132
et al0.571194
genetically modified cells0.552195
hematopoietic stem cells0.563457
immortal hybridoma cells0.568993
CLICK HERE
1776 National Cancer Institute Html es La nutrición en el tratamiento del cáncer (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca de las causas y el tratamiento de los problemas de nutrición que se presentan en pacientes de cáncer.
Oncology Nutrition Dietetic0.794305
Nutrition risk screening0.380015
Perioperative nutrition support0.325434
August DA0.321534
Bergerson S0.42802
medical oncology patients0.319644
American Cancer Society0.354235
Malnutrition Screening Tool0.336109
American Society0.333545
Adult Oncology Patient0.321746
Cancer Res0.323371
nutrition interventions across0.325357
Leser M0.456946
cancer patients0.534602
Hematol Oncol Clin0.319076
Enteral Nutrition0.453095
oncology patient0.475881
Parenter Enteral Nutr0.377081
Nutrition Risk Screening-20020.325017
nutrition therapy0.376862
pacientes quizás0.322377
Nutrition Dietetic Practice0.754692
Medical nutrition therapy0.368433
Subjective Global Assessment0.322733
terapia nutricional0.340919
surgical oncology patients0.340122
clinical practice0.555659
Radiation Oncology Nursing0.334481
Care Cancer0.324544
Academy’s Oncology Nutrition0.372909
Dietetic Practice Group0.607536
nutrition risk0.383416
Modern Nutrition0.321534
Oncology Nutrition Evidence0.344953
Oncology Nursing Practice0.345995
Top Clin Nutr0.321751
Nutrition assessment0.344971
nutrition impact symptoms0.345866
Clin Nutr0.326461
cancer cachexia0.388006
Clinical Nutrition0.351661
Clin Oncol0.323666
nutrition support therapy0.32555
Ledesma N0.427589
Oncology Nursing Society0.390831
Oncology Nutrition0.930511
Oncology Nursing0.416659
Patient-Generated Subjective Global0.319243
Nutrition management0.340043
CLICK HERE
1848 National Cancer Institute Html es Tratamiento del cáncer de piel (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del cáncer de piel.
Compton CC0.427006
ángulo nariz-mejilla0.312075
Cutaneous squamous0.410175
criocirugía frente0.310658
skin cancers0.337834
señalización tipo erizo0.316126
basal-cell carcinoma0.31436
American Cancer Society0.31065
Casciato DA0.3104
7th ed0.425796
Dermatol Surg Oncol0.322688
TFD frente0.31135
cutaneous carcinomas0.448478
Mohs surgery is0.310939
Plast Reconstr Surg0.318551
carcinomas cutáneos0.316845
Estados Unidos0.319384
Natl Cancer Inst0.311163
human papillomavirus infection0.320874
CCE invasor0.312649
Euros frente0.310849
N2a Metástasis0.310265
cell carcinomas0.926899
escisión frente0.315633
Arch Dermatol0.342458
Carcinoma apocrino0.319357
uncomplicated basal cell0.313087
Invest Dermatol0.31893
Mohs micrographic surgery0.311178
micosis fungoide0.313548
Cancer Staging Manual0.594205
recidivas locales0.316877
PDQ Tratamiento0.321192
New York0.409746
Day CL Jr0.315276
clasificación tnm0.310941
células escamosas cutáneos0.311636
Dermatol Surg0.324225
Byrd DR0.419056
T2b Tumor0.314992
Karagas MR0.311264
basal cell carcinomas0.750035
American Joint Committee0.344157
párpadoa aReproducción0.326393
tumor fotosensibilizadores0.313881
Tis Carcinoma0.334823
Carcinoma arising0.318249
AJCC Cancer Staging0.604512
Edge SB0.427178
CLICK HERE
1878 National Cancer Institute Html es Tratamiento del cáncer de seno (mama) masculino (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del cáncer de seno (mama) masculino.
Giordano SH0.546628
Italian Oncology Group0.503266
aromatase inhibitors0.504835
Sin embargo0.505052
accessed october0.502081
American Cancer Society0.521913
sumario tratamiento0.50893
PALB2 mutations0.502161
Terapia sistémica preoperatoria0.504717
Instituto Nacional0.507139
Vlamis V0.505558
male breast0.773618
DeVita VT Jr0.502939
Wong GY0.505822
population-based study0.506079
carcinoma lobulillar0.502812
hereditary male breast0.514858
estadificación tnm0.502579
Buzdar AU0.511225
breast carcinoma0.529746
German Breast Group0.523976
Adjuvant therapy with0.503518
male breast carcinoma0.523697
Cancer Facts0.511201
parientes mujeres0.50281
tumores pten0.506695
Cancer Res Treat0.581998
National Cancer Institute0.509524
or without gonadotropin-releasing0.502999
PDQ Tratamiento0.571327
versus ia0.508803
Hortobagyi GN0.519998
Intern Med0.505973
cancer susceptibility0.510328
cases from0.502419
metastatic breast0.510618
Clin Oncol0.505305
IA vs0.504284
Physician Data Query0.502682
breast cancer0.966614
estadios tnm0.502728
Oncology Group Phase0.503374
Aromatase inhibitors with0.503642
PDQ Sofocos0.507587
Current management0.505493
Oncology Group0.504752
Borgen PI0.505535
Hormonal treatment0.502423
Breast Cancer Res0.608904
CLICK HERE
2031 National Cancer Institute Html es Tratamiento de la enfermedad trofoblástica de la gestación (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento de la enfermedad trofoblástica de la gestación.
Glándula tiroidea hiperactiva0.562015
maligna.Molas invasoras0.545444
siguientes procedimientos0.560552
estadio iv0.537226
siguientes aspectos0.546924
tumores trofoblásticos epitelioides0.805684
molas invasoras0.909175
vía oral0.5248
rayos x0.529833
enlace drugs approved0.541637
gonadotropina coriónica huma0.544512
Gestational Trophoblastic Disease0.542392
National Cancer Institute0.526399
ecografía transvaginal0.535921
siguientes riesgos0.522487
Instituto Nacional0.591908
áreas anormales.ampliar examen0.55209
cuerpo elabora hormona0.593063
PDQ Tratamiento0.555876
gestación causa efectos0.735263
molares.ampliar dilatación0.527024
partes distantes0.78863
siguientes factores0.551671
Physician Data Query0.592879
estadio i0.537379
último panel0.524777
estadio iii0.537123
término enfermedad0.57453
siguientes operaciones0.536826
histerectomía laparoscópica total.Ampliar0.550873
siguientes enlaces0.525533
histerectomía abdominal0.531238
siguientes pruebas0.60278
CLICK HERE
16843 National Cancer Institute Html en Massachusetts General Hospital and Harvard Univeristy — Imaging of Nanotherapeutic Drug Action In vivo imaging analyses of therapeutic nanoparticles (TNP), addressing key questions on nanoparticle distribution (pharmacokinetics, PK) and cellular response (pharmacodynamics, PD).
nanoparticle distribution0.841511
enhanced MR imaging0.924949
biological understanding0.766676
Alliance members0.763245
M.D.0.664358
vivo imaging analyses0.983793
Claudio Vinegoni0.829503
Cesar Castro0.816804
cancer cells0.772225
NCI Alliance0.790962
Ph.D0.666483
project team0.768015
considerable proportion0.780069
clinical data0.766134
recent developments0.775301
multimodality imaging0.800032
larger number0.783733
affinity ligands0.782978
cancer nanotechnology questions0.94124
Ralph Weissleder0.799712
TNP0.654222
free survival0.789955
vivo imaging technologies0.994916
nano-encapsulated chemotherapeutics0.788661
recent feasibility studies0.924078
lower toxicity0.785357
cancer members0.792525
molecular diagnostics0.779336
new strategy0.77113
following questions0.766532
new constructs0.797665
new biological insight0.926895
vivo setting0.83945
tumoral accumulation0.816621
temporal heterogeneity0.803444
key questions0.775023
future interactions0.756886
efficacy0.740414
tumoral myeloid cells0.915593
Principal Investigators0.797013
tumor cell accumulation0.959124
therapeutic nanoparticles0.774355
molecular / cell0.763144
occasionally improved progression0.958519
Mikael Pittet0.837942
cancer biology0.77172
Alliance projects0.764335
CLICK HERE
17186 National Cancer Institute Html en TMIST (Tomosynthesis Mammographic Imaging Screening Trial) TMIST is a randomized breast screening trial that compares two Food and Drug Administration (FDA)-approved types of digital mammography, standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D).
routine screening mammogram0.506393
entire study group0.421549
tomosynthesis mammography0.449515
health plans0.41281
3-D mammography0.660743
trial0.465454
breast cancer status0.514295
standard digital mammography0.512193
3-D mammogram0.462356
women ages0.504522
following factors0.42666
breast biopsies0.439927
fewer false-positive test0.416422
researchers0.394009
2-D screening mammograms0.502737
mammography clinics0.435449
aggressive breast cancers0.493477
ECOG-ACRIN Cancer Research0.42875
2-D mammography0.505053
3-D mammograms0.447984
hormone replacement therapy0.765582
randomized breast0.472367
personal risk factors0.42803
primary care doctors0.417168
women0.662197
risk changes0.412147
fewer harder-to-treat cancers0.422139
study0.460399
best ways0.450667
mammograms0.529145
age group0.430585
certain groups0.456471
breast cancers0.534289
dense breasts0.527755
complete cost0.412269
premenopausal women0.386263
routine mammogram0.443785
mammogram0.569066
3-D mammography machines0.510266
3-D mammography images0.549905
breast cancer screening0.609852
newly diagnosed breast0.491574
nearby lymph node0.415404
breast cancer0.940336
trial record0.381013
tissue samples0.430822
genetic changes0.428717
Women’s health0.38389
family history0.510755
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.